Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development
Model-based Meta-analysis is a framework to compare drugs used to treat diabetic peripheral neuropathy, post-herpetic neuralgia & fibromyalgia.
Year: 2019
LEO Pharma Joins Certara’s PBPK Simcyp Simulator Consortium
PRINCETON, NJ – Dec. 10, 2019 – LEO Pharma has licensed Certara’s proprietary Simcyp®️ Population-based Simulator and joined its Consortium.
The Expanding Role of Natural History Studies in Drug Development
Natural history studies follow a group of people over time who have or are at risk of developing a specific disease. This type of study is an important tool in modern drug development and in assessing new health technologies by payers. This is especially true for rare diseases or diseases with high, unmet medical need … Continued
Effectively Developing Cutting-edge Mobile Tools for Market Access
This webinar explained how to conceptualize, optimize, and kick-off your mobile tool development process.
What’s New in the Simcyp Simulator v19?
This webinar explained how the latest updates in the Simcyp Simulator v19, Certara’s physiologically-based pharmacokinetic (PBPK) modeling and simulation platform, will support developing safer, more effective medications faster.
Rare Diseases: Bridging the Gap between Drug Manufacturers and Payers
High prices for drugs for rare diseases have introduced uncertainties from payers around whether a medication’s value justifies its price.
Certara Announces the Availability of PK Submit, its Pharmacokinetic CDISC Technology Solution
November 21, 2019 PK Submit generates PK CDISC domains automatically, allowing sponsors to file regulatory submissions faster, while also improving data organization and compliance
Leveraging Model-based Meta-analysis to Inform Drug Development Decisions
Model-based meta-analysis is a quantitative framework that uses PK/PD and statistical modeling of external data to inform drug development decisions.
Patient Engagement and Patient Centricity Series Part III: Engaging with The Right Patients for the Right Purpose
Nirpal Virdee, Synchrogenix’s Global Head of Transparency and Disclosure recently sat down with Trishna Bharadia, award-winning health advocate and patient engagement champion, for a discussion around patient engagement and patient centricity. Their discussion was moderated by Darshan Kulkarni of the podcast ‘Darshan Talks’ for a series of episodes that you can listen to here. Darshan … Continued
Patient Engagement and Patient Centricity Series Part II: Types of Patient Advocates
Nirpal Virdee, Synchrogenix’s Global Head of Transparency and Disclosure recently sat down with Trishna Bharadia, award-winning health advocate and patient engagement champion, for a discussion around patient engagement and patient centricity. Their discussion was moderated by Darshan Kulkarni of the podcast ‘Darshan Talks’ for a series of episodes that you can listen to here. Darshan … Continued